<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Suamnbutler - Latest News</title>
<link href="https://news.press-release-wire.com/rss/suamnbutler/latest.xml"></link>
<updated>2026-07-19T15:23:29+00:00</updated>
<id>urn:uuid:197abeb9-6946-a18c-7675-be81e11aab07</id>
<entry>
<title>The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis</title>
<link href="https://news.press-release-wire.com/@suamnbutler/the-subcutaneous-biologic-drugs-and-affiliated-technologies-market-is-projected-to-be-worth-over-usd-180-billion-by-2030-predicts-roots-analysis-ndeq6rpnyqam"></link>
<id>urn:uuid:0ea6aa5c-4fb3-e2b5-efba-78a21153f6dd</id>
<summary type="html"><![CDATA[Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals]]></summary>
<updated>2021-08-05T10:24:00+00:00</updated>
</entry>
<entry>
<title>The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics</title>
<link href="https://news.press-release-wire.com/@suamnbutler/the-targeted-protein-degradation-enabling-technologies-market-featuring-a-healthy-pipeline-of-novel-therapeutics-4jeqjdmw8qwm"></link>
<id>urn:uuid:f710bcf9-e222-70dd-4610-88187da7a3bc</id>
<summary type="html"><![CDATA[Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare]]></summary>
<updated>2021-08-05T10:19:16+00:00</updated>
</entry>
</feed>